CTRI/2023/08/056046
Not yet recruiting
未知
A Clinical Study on Diabetic Peripheral Neuropathy and Comparative Evaluation of Asbi with Standard Control in its Management - NI
Department of Moalejat Ajmal Khan Tibbiya College And Hospital Aligarh Muslim University Aligarh0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Sponsor
- Department of Moalejat Ajmal Khan Tibbiya College And Hospital Aligarh Muslim University Aligarh
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical Diagnosed Patients of Diabetic Peripheral Neuropathy With Type 2 Diabetes Mellitus Through Toronto Clinical Neuropathy Score.
- •Fasting Blood Sugar Less than or equal to 150 mg/dl.
- •HbA1c Less than or equal to 8\.
- •Vibration Perception Test upto Moderate Loss of Vibration Perception Evaluated by Diabetic Risk Profiler.
- •Washout Period of 20 Days for Patients Who Were Already Taking Any Drug for Neuropathy.
- •Patient Willing To Participate And Follow The Instructions.
Exclusion Criteria
- •Patient below 30 Years and Above 60 Years of Age.
- •Physiological Status: Pregnancy and Lactation.
- •Pathological Status: Cardiovascular, Renal, Hepatic Diseases and Thyroid Dysfunction.
- •Complications of Diabetes Other Than Diabetic Peripheral Neuropathy.
- •Clinically Suspected Case of Neuropathy Other Than Diabetes.
- •Patient Having Ischemic or Neuropathic Ulcer
- •Alcoholic Patients.
- •Patients Taking Neurotoxic Drugs.
- •Uncontrolled Cases of Diabetes Mellitus. HbA1c \> 8\.
- •Severe Loss of Vibration Sensation. Vibration Perception Test Value \> 25 Volts.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Role of Methylcobalamine in Type 2 Diabetes Mellitus patientsHealth Condition 1: E114- Type 2 diabetes mellitus with neurological complicationsHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complicationsCTRI/2020/06/026074self sponsored intramural
Not yet recruiting
Not Applicable
Occurrence of Peripheral neuropathy in patients of Type 2 DiabetesCTRI/2024/03/064317Ayurswasthya Yojana, Centre of excellence Scheme, Ministry of Ayush, Govt of India
Terminated
Not Applicable
Diabetic peripheral neuropathy treatment with dorsal root ganglion stimulation – the PENTAGONS trialPainful diabetic neuropathyNervous System DiseasesISRCTN40062191niversity of Oxford2
Completed
Not Applicable
Impact of Peripheral Neuropathy in Type-II Diabetes Mellitus on Outcome Measures of Weight-Bearing Aerobic Training in Post-Myocardial Infarction Patients.PACTR201903732765841Department of Cardiology and Department of Physical Medicine and Rehabilitation35
Completed
Not Applicable
Effect of Vitamin D in Patients With Diabetic Peripheral Neuropathy to Alleviate Pain and Improvement of SymptomsDiabetic Peripheral NeuropathyNCT04984044Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh72